Mordor Intelligence has published a new report on the Peptide Therapeutics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Peptide Therapeutics Market is anticipated to grow from USD 46.36 billion in 2025 to USD 65.20 billion by 2030, registering a compound annual growth rate (CAGR) of 7.06% over the forecast period (2025-2030). The market’s growth is fueled by the increasing prevalence of cancer and metabolic disorders, growing investments in the research and development of innovative drugs, and advancements in peptide therapeutic technologies.
Key Trends Driving Market Growth
- Increasing Prevalence of Chronic DiseasesThe rising incidence of chronic diseases, such as cancer and metabolic disorders, is a significant driver of the peptide therapeutics market. Peptides offer distinct advantages due to their specificity and ability to target multiple biological pathways, making them effective in treating various chronic conditions.
- Technological Advancements in Peptide TherapeuticsAdvancements in peptide synthesis and formulation technologies have enhanced the stability, bioavailability, and efficacy of peptide-based drugs. These technological improvements have expanded the therapeutic applications of peptides, contributing to market growth.
- Rising Investments in Research and DevelopmentThere is a growing trend of increased investments in the research and development of novel peptide-based therapeutics. This surge in R&D activities is leading to the discovery of new therapeutic peptides and the expansion of the market.
Market Segmentation
The peptide therapeutics market is segmented based on marketing type, application, route of administration, and geography:
- By Marketing Type:
- Generic: Peptide drugs that are bioequivalent to branded counterparts.
- Branded: Proprietary peptide drugs developed and marketed by pharmaceutical companies.
- By Application:
- Gastrointestinal Disorders: Peptide therapeutics used in the treatment of various gastrointestinal conditions.
- Neurological Disorders: Peptides targeting neurological pathways to manage disorders.
- Metabolic Disorders: Peptide-based treatments for conditions like diabetes and obesity.
- Cancer: Therapeutic peptides employed in oncology for targeted cancer therapy.
- Other Applications: Includes cardiovascular diseases, infectious diseases, and more.
- By Route of Administration:
- Oral: Development of oral peptide formulations to improve patient compliance.
- Other Routes of Administration: Includes transdermal, intranasal, and pulmonary routes.
- By Geography:
- Europe: Significant market presence with ongoing research and development activities.
- Asia-Pacific: Fastest-growing region due to increasing healthcare investments and rising prevalence of chronic diseases.
- Middle East and Africa: Gradual market growth with improving healthcare infrastructure.
- South America: Emerging market with potential growth opportunities.
Get a Customized Report Tailored to Your Requirements: https://www.mordorintelligence.com/market-analysis/synthetic-compounds
Key Players
The peptide therapeutics market features several prominent companies contributing to its growth:
- Amgen Inc.: A leading biotechnology company specializing in the development of innovative peptide-based therapeutics.
- Bayer AG: A global enterprise with a diverse portfolio, including significant contributions to peptide drug development.
- Boehringer Ingelheim International GmbH: Focuses on researching and developing peptide therapeutics for various therapeutic areas.
- Johnson & Johnson: Engages in the development and commercialization of peptide-based drugs across multiple medical fields.
- Pfizer Inc.: A pharmaceutical giant actively involved in the research and production of peptide therapeutics.
These companies are actively engaged in research and development to introduce innovative peptide-based products and expand their market presence globally.
Conclusion
The global peptide therapeutics market is on a robust growth trajectory, projected to reach USD 65.20 billion by 2030. This expansion is fueled by the increasing prevalence of chronic diseases, technological advancements in peptide therapeutics, and rising investments in research and development. As key industry players continue to innovate and address the evolving needs of healthcare providers and patients, the peptide therapeutics market is expected to experience sustained growth
Industry Related Reports
Peptide and Anticoagulant Drugs Market: The Peptide and Anticoagulant Drugs Market Report is categorized by route of administration, including Peptide Drugs (Parenteral, Oral, Mucosal, and Other Routes of Administration) and Anticoagulant Drugs (Oral and Injectable). It is further segmented by application, covering Peptide Drugs (Gastrointestinal Disorders, Cardiovascular Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and Other Applications) and Anticoagulant Drugs (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Other Applications). Additionally, the market analysis spans geographic regions, including North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Peptide Drug Conjugates Market: The Peptide Drug Conjugates Market is segmented by type, including Therapeutic and Diagnostic applications, by disease, covering Gastroenteropancreatic Neuroendocrine Tumors, Multiple Myeloma, and Other Diseases, and by geography, spanning North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Peptide Synthesis Market: The Peptide Synthesis Market Report is categorized by technology, including Solid-Phase, Liquid-Phase, and Hybrid and Recombinant methods. It is further segmented by product, covering Equipment, Reagents and Consumables (such as Enzymes and Others), and Services. The market is also divided by end users, comprising Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), and Academic and Research Institutes. Additionally, the geographic analysis includes North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
media@mordorintelligence.com
https://www.mordorintelligence.com/